ChengDu ShengNuo Biotec Co.,Ltd.

SHSE:688117 Voorraadrapport

Marktkapitalisatie: CN¥3.1b

ChengDu ShengNuo BiotecLtd Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yongjun Wen

Algemeen directeur

CN¥748.8k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.2%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 04
ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable

Aug 26
ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable

A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)

Jun 19
A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)

ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues

Apr 29
ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues

There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump

Mar 04
There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump

CEO

Yongjun Wen (59 yo)

no data

Tenure

CN¥748,800

Compensatie

Mr. Yongjun Wen serves as Chairman and General Manager at ChengDu ShengNuo Biotec Co., Ltd. he serves as a Consultant at Roton Capital Management Co., Ltd. Mr. Wen has experience in peptide drug CDMO proje...